Clinical Trials
19 trialsNCT06098755 2026-02-04
The Sequestration of Holistic Stress Management Techniques for Adults
Virtual Tribunal Monastery
Phase NA Withdrawn
NCT05538689 2025-09-29
SOUL
University of Chicago
Phase 4 Withdrawn
NCT06058728 2025-09-17
Pink Orchid
AbbVie
Withdrawn
NCT05568940 2024-05-30
eTAPE
McGill University Health Centre/Research Institute of the McGill University Health Centre
Withdrawn
NCT00180739 2023-10-24
Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future
Imperial College London
Phase 4 Withdrawn
NCT02703246 2023-06-05
Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes
George Washington University
Phase NA Withdrawn
NCT01735812 2022-06-13
UFREEZE-01
IceCure Medical Ltd.
Phase NA Withdrawn
NCT04567095 2020-10-23
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada
Allergan
Withdrawn
NCT04567589 2020-10-22
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada
Allergan
Withdrawn
NCT03699176 2020-01-18
ASTEROID 7
Bayer
Phase 3 Withdrawn
NCT01328067 2018-06-15
Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids
InSightec
Phase NA Withdrawn
NCT00827645 2018-05-22
Uterine Artery Embolization and Pelvic Floor Symptoms
University of Texas Southwestern Medical Center
Withdrawn
NCT02736435 2018-02-06
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
Thunder Bay Regional Health Research Institute
Phase 3 Withdrawn
NCT01971060 2017-01-25
VLocmyo
The Advanced Gynecologic Surgery Institute
Phase NA Withdrawn
NCT01671215 2015-04-15
Endometrial and Myometrial Changes, With and Without Fibroids
Meir Medical Center
Withdrawn
NCT00874302 2014-06-27
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Repros Therapeutics Inc.
Phase 3 Withdrawn
NCT00768742 2013-11-25
FAST
Gynesonics
Phase NA Withdrawn
NCT01553123 2013-02-07
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Watson Pharmaceuticals
Phase 3 Withdrawn
NCT00945360 2012-07-13
Aromatase Inhibitors for Treatment of Uterine Leiomyomas
American University of Beirut Medical Center
Phase 1 Withdrawn